How Emotional Granularity Helps Build Resilience in Young and Middle-Aged Colorectal Cancer Survivors

NCT ID: NCT07200388

Last Updated: 2025-10-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

236 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-30

Study Completion Date

2026-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to understand how the ability to identify and describe specific emotions (called "emotional granularity") influences coping and adaptation ("resilience") in young and middle-aged colorectal cancer survivors.

The main questions to be answer are:

1. How does emotional granularity help build resilience during cancer recovery?
2. How does emotion regulation contribute to resilience building?
3. What specific emotional needs and challenges do survivors experience?

This is an observational study where no experimental treatments are provided. Participants will complete an online questionnaire about background, emotions, ways of managing emotions, and ability to cope with stress. A subset of participants will then be invited to take part in a private, 30-60 minute interview to share personal experiences and feelings in more detail.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Colorectal cancer (CRC) is a major global public health concern with rising incidence and mortality rates globally. While advances in treatment have improved survival rates, young and middle-aged survivors face unique and complex challenges, including severe emotional distress, disrupted social networks, work-related economic toxicity and concerns regarding fertility, that necessitate tailored psychosocial interventions. Resilience, defined as a dynamic psychosocial outcome enabling individuals to adapt to adversity, has emerged as a crucial determinant of quality of life among CRC survivors. Adaptive emotion regulation is fundamental to fostering resilience, yet existing emotional interventions have predominantly provided general emotion regulation strategies without addressing patients' proficiency in effectively applying these strategies. Emotional granularity, the ability to differentiate and label subtle emotional experiences, is posited to enhance emotion regulation efficacy.

Therefore, to generate an evidence-based blueprint for emotion-focused psychosocial programs designed to strengthen resilience and enhance quality of life among young and middle-aged colorectal cancer survivors. This sequential mixed-methods investigation aims to clarify how emotional granularity influences resilience through emotion regulation, to explore survivors' emotional needs, and to provide evidence for the future intervention design. The inclusion criteria are (1) young and middle-aged adult patients (18-60 years); (2) patients diagnosed with CRC; (3) patients have completed primary treatments without experiencing a recurrence of CRC; and (4) patients able to use a smartphone and agree to participate in the study. The exclusion criteria are (1) patients who have not been informed of their cancer diagnosis due to family decision to withhold information; and (2) patients suffering from severe conditions that may affect participation or assessment.

A cross-sectional questionnaire will first be employed to examine the mediating role of emotion regulation in the relationship between emotional granularity and resilience after providing informed consent. Measures will include demographic information and the Chinese versions of the Range and Differentiation of Emotional Experience Scale, the Difficulties in Emotion Regulation Scale and the 10-item Connor-Davidson Resilience Scale. A total of 236 participants will be recruited from teaching hospitals of Soochow University and Jiangsu University, Suzhou, Jiangsu province. Mediation analysis will examine whether emotion regulation channels the effect of emotional granularity on resilience. The second phase will involve individual, semi-structured interviews lasting thirty to sixty minutes each, purposively sampling 20-25 participants with high, medium and low scores from the first phase.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer (CRC)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Young and Middle-Aged CRC Survivors

This single cohort consists of young and middle-aged adult survivors of colorectal cancer. All participants will complete the quantitative survey phase. A subset of participants, purposively sampled based on their survey scores, will then be invited to participate in the qualitative interview phase. There is no intervention administered; this is an observational study examining the relationships between emotional granularity, emotion regulation, and resilience.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Young and middle-aged adult patients (age in the range of 18-60 years);
* Patients diagnosed with CRC;
* Patients have completed primary treatments (e.g., surgery, chemotherapy, and/or radiotherapy) without experiencing a recurrence of CRC;
* Patients able to use a smartphone and agree to participate in the study.

Exclusion Criteria

* Patients who have not been informed of their cancer diagnosis due to family decision to withhold information;
* Patients suffering from severe conditions that may affect participation or assessment, such as significant cognitive impairment, psychiatric disorders, or communication disorder.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The First Affiliated Hospital of Soochow University

OTHER

Sponsor Role collaborator

Second Affiliated Hospital of Soochow University

OTHER

Sponsor Role collaborator

Kunshan First People's Hospital Affiliated to Jiangsu University

INDUSTRY

Sponsor Role collaborator

The Hong Kong Polytechnic University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr Joyce Chung

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kunshan First People's Hospital Affiliated to Jiangsu University

Suzhou, Jiangsu, China

Site Status

The Second Affiliated Hospital of Soochow University

Suzhou, Jiangsu, China

Site Status

The First Affiliated Hospital of Soochow University

Suzhu, Jiangsu, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Joyce Oi Kwan Chung, PhD

Role: CONTACT

852-27666322

Jiyin Zhang, MSN

Role: CONTACT

86-13578077817

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Juan Song, MSN

Role: primary

86-13862596317

Li Tian, PhD

Role: primary

86-13862596317

Li Tian, PhD

Role: primary

86-13862596317

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HSEARS20250802001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.